The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer’s Disease

Adams SL, Tilton K, Kozubek JA, Seshadri S, Delalle I (2016) Subcellular changes in bridging integrator 1 protein expression in the cerebral cortex during the progression of Alzheimer disease pathology. J Neuropathol Exp Neurol 75:779–790. https://doi.org/10.1093/jnen/nlw056 Andrew RJ et al (2019) Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model. J Biol Chem 294:4477–4487. https://doi.org/10.1074/jbc.RA118.006379 Aoyagi A et al (2019) Abeta and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aat8462 Bamberger ME, Harris ME, McDonald DR, Husemann J, Landreth GE (2003) A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci Off J Soc Neurosci 23:2665–2674 Bhatia VK, Madsen KL, Bolinger PY, Kunding A, Hedegard P, Gether U, Stamou D (2009) Amphipathic motifs in BAR domains are essential for membrane curvature sensing. EMBO J 28:3303–3314. https://doi.org/10.1038/emboj.2009.261 Cacace R, Sleegers K, Van Broeckhoven C (2016) Molecular genetics of early-onset Alzheimer’s disease revisited. Alzheimer’s & Dementia J Alzheimer’s Assoc 12:733–748. https://doi.org/10.1016/j.jalz.2016.01.012 Cai Z, Xiao M (2016) Oligodendrocytes and Alzheimer’s disease. Int J Neurosci 126:97–104. https://doi.org/10.3109/00207454.2015.1025778 Calafate S, Flavin W, Verstreken P, Moechars D (2016) Loss of Bin1 promotes the propagation of Tau pathology. Cell Rep 17:931–940. https://doi.org/10.1016/j.celrep.2016.09.063 Caldwell JL, Smith CE, Taylor RF, Kitmitto A, Eisner DA, Dibb KM, Trafford AW (2014) Dependence of cardiac transverse tubules on the BAR domain protein amphiphysin II (BIN-1). Circ Res 115:986–996. https://doi.org/10.1161/circresaha.116.303448 Cassimere EK, Pyndiah S, Sakamuro D (2009) The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage. Cell Death Differ 16:1641–1653. https://doi.org/10.1038/cdd.2009.98 Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157:277–286 Chakroborty S, Stutzmann GE (2011) Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction. Sci China Life Sci 54:752–762. https://doi.org/10.1007/s11427-011-4205-7 Chang MY et al (2007) Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer. Cancer Res 67:7605–7612. https://doi.org/10.1158/0008-5472.can-07-1100 Chapuis J et al (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18:1225–1234. https://doi.org/10.1038/mp.2013.1 Chia PZ, Toh WH, Sharples R, Gasnereau I, Hill AF, Gleeson PA (2013) Intracellular itinerary of internalised beta-secretase, BACE1, and its potential impact on beta-amyloid peptide biogenesis. Traffic (Copenhagen, Denmark) 14:997–1013. https://doi.org/10.1111/tra.12088 Cirrito JR et al (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58:42–51. https://doi.org/10.1016/j.neuron.2008.02.003 Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19:R12–20. https://doi.org/10.1093/hmg/ddq160 Crotti A et al (2019) BIN1 favors the spreading of Tau via extracellular vesicles. Sci Rep 9:9477. https://doi.org/10.1038/s41598-019-45676-0 Das U, Scott DA, Ganguly A, Koo EH, Tang Y, Roy S (2013) Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79:447–460. https://doi.org/10.1016/j.neuron.2013.05.035 De Rossi P et al (2016) Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Mol Neurodegener 11:59. https://doi.org/10.1186/s13024-016-0124-1 De Rossi P et al (2017) BIN1 localization is distinct from Tau tangles in Alzheimer’s disease. Matters. https://doi.org/10.19185/matters.201611000018 De Rossi P et al (2019) Aberrant accrual of BIN1 near Alzheimer’s disease amyloid deposits in transgenic models. Brain Pathol (Zurich, Switzerland) 29:485–501. https://doi.org/10.1111/bpa.12687 Du Yan S et al (1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94:5296–5301. https://doi.org/10.1073/pnas.94.10.5296 DuHadaway JB, Lynch FJ, Brisbay S, Bueso-Ramos C, Troncoso P, McDonnell T, Prendergast GC (2003) Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer. J Cell Biochem 88:635–642. https://doi.org/10.1002/jcb.10380 Efthymiou AG, Goate AM (2017) Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener 12:43. https://doi.org/10.1186/s13024-017-0184-x El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382:716–719. https://doi.org/10.1038/382716a0 Elliott K et al (1999) Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene 18:3564–3573. https://doi.org/10.1038/sj.onc.1202670 Elliott K, Ge K, Du W, Prendergast GC (2000) The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 19:4669–4684. https://doi.org/10.1038/sj.onc.1203681 Esmailzadeh S, Huang Y, Su MW, Zhou Y, Jiang X (2015) BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma. Leukemia 29:1402–1413. https://doi.org/10.1038/leu.2015.9 Fassbender K et al (2004) The LPS receptor (CD14) links innate immunity with Alzheimer’s disease. FASEB J Off Pub Fed Am Soc Exp Biol 18:203–205. https://doi.org/10.1096/fj.03-0364fje Franzmeier N, Rubinski A, Neitzel J, Ewers M (2019) The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun 10:1766. https://doi.org/10.1038/s41467-019-09564-5 Frost A, Unger VM, De Camilli P (2009) The BAR domain superfamily: membrane-molding macromolecules. Cell 137:191–196. https://doi.org/10.1016/j.cell.2009.04.010 Fugier C et al (2011) Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med 17:720–725. https://doi.org/10.1038/nm.2374 Galderisi U et al (1999) Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein. J Cell Biochem 74:313–322 Gatz M et al (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63:168–174. https://doi.org/10.1001/archpsyc.63.2.168 Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, Prendergast GC (1999) Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Nat Acad Sci USA 96:9689–9694. https://doi.org/10.1073/pnas.96.17.9689 Ge K, Duhadaway J, Sakamuro D, Wechsler-Reya R, Reynolds C, Prendergast GC (2000) Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Int J Cancer 85:376–383 Ghaneie A et al (2007) Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival. Cancer Biol Ther 6:192–194. https://doi.org/10.4161/cbt.6.2.3587 Glennon EB, Whitehouse IJ, Miners JS, Kehoe PG, Love S, Kellett KA, Hooper NM (2013) BIN1 is decreased in sporadic but not familial Alzheimer’s disease or in aging. PLoS ONE 8:e78806. https://doi.org/10.1371/journal.pone.0078806 Guimas Almeida C, Sadat Mirfakhar F, Perdigao C, Burrinha T (2018) Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production. Cell Mol Life Sci 75:2577–2589. https://doi.org/10.1007/s00018-018-2825-9 Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358–372. https://doi.org/10.1038/nrn3880 Holler CJ, Davis PR, Beckett TL, Platt TL, Webb RL, Head E, Murphy MP (2014) Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer’s disease brain and correlates with neurofibrillary tangle pathology. J Alzheimer’s Dis 42:1221–1227. https://doi.org/10.3233/jad-132450 Hong TT et al (2010) BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol 8:e1000312. https://doi.org/10.1371/journal.pbio.1000312 Hong T et al (2014) Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. Nat Med 20:624–632. https://doi.org/10.1038/nm.3543 Ishii A et al (2009) Human myelin proteome and comparative analysis with mouse myelin. Proc Natl Acad Sci USA 106:14605–14610. https://doi.org/10.1073/pnas.0905936106 Jantaratnotai N, Ryu JK, Kim SU, McLarnon JG (2003) Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. NeuroReport 14:1429–1433. https://doi.org/10.1097/00001756-200308060-00005 Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM (2012) Expression of novel Alzheimer’s disease risk genes in control and Alzheimer’s disease brains. PLoS ONE 7:e50976. https://doi.org/10.1371/journal.pone.0050976 Kauwe JS et al (2011) Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer’s disease. PLoS ONE 6:e15918. https://doi.org/10.1371/journal.pone.0015918 Khachaturian ZS (1989) Calcium, membranes, aging, and Alzheimer’s disease. Introduction and overview. Ann NY Acad Sci 568:1–4. https://doi.org/10.1111/j.1749-6632.1989.tb12485.x Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D (2008) Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. J Cell Physiol 216:621–631. https://doi.org/10.1002/jcp.21437 Koenigsknecht J, Landreth G (2004) Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci Off J Soc Neurosci 24:9838–9846. https://doi.org/10.1523/jneurosci.2557-04.2004 La Joie R et al (2018) Associations between [(18)F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology 90:e282–e290. https://doi.org/10.1212/wnl.0000000000004860 Lambert JC et al (2011) Evidence of the association of BIN1 and PICALM with the AD risk in contrasting. Eur Popul Neurobiol Aging 32:756.e711–755. https://doi.org/10.1016/j.neurobiolaging.2010.11.022 Lee E et al (2002) Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science (New York, NY) 297:1193–1196. https://doi.org/10.1126/science.1071362 Leprince C, Le Scolan E, Meunier B, Fraisier V, Brandon N, De Gunzburg J, Camonis J (2003) Sorting nexin 4 and amphiphysin 2, a new partnership between endocytosis and intracellular trafficking. J Cell Sci 116:1937–1948. https://doi.org/10.1242/jcs.00403 Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951–7955. https://doi.org/10.1073/pnas.90.17.7951 Malki I, Cantrelle FX, Sottejeau Y, Lippens G, Lambert JC, Landrieu I (2017) Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins—role of the SH3 domain. FEBS J 284:3218–3229. https://doi.org/10.1111/febs.14185 Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120–129. https://doi.org/10.1038/35040009 Mitew S, Kirkcaldie MT, Halliday GM, Shepherd CE, Vickers JC, Dickson TC (2010) Focal demyelination in Alzheimer’s disease and transgenic mouse models. Acta Neuropathol 119:567–577. https://doi.org/10.1007/s00401-010-0657-2 Miyagawa T et al (2016) BIN1 regulates BACE1 intracellular trafficking and amyloid-beta production. Hum Mol Genet 25:2948–2958. https://doi.org/10.1093/hmg/ddw146 Nakajo A et al (2016) EHBP1L1 coordinates Rab8 and Bin1 to regulate apical-directed transport in polarized epithelial cells. J Cell Biol 212:297–306. https://doi.org/10.1083/jcb.201508086 Negorev D, Riethman H, Wechsler-Reya R, Sakamuro D, Prendergast GC, Simon D (1996) The Bin1 gene localizes to human chromosome 2q14 by pcr analysis of somatic cell hybrids and fluorescence in situ hybridization. Genomics 33:329–331 Nicot AS et al (2007) Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39:1134–1139. https://doi.org/10.1038/ng2086 Nishimura M, Tomimoto H, Suenaga T, Namba Y, Ikeda K, Akiguchi I, Kimura J (1995) Immunocytochemical characterization of glial fibrillary tangles in Alzheimer’s disease brain. Am J Pathol 146:1052–1058 Peter BJ, Kent HM, Mills IG, Vallis Y, Butler PJ, Evans PR, McMahon HT (2004) BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science (New York, NY) 303:495–499. https://doi.org/10.1126/science.1092586 Piaceri I, Nacmias B, Sorbi S (2013) Genetics of familial and sporadic Alzheimer’s disease. Front Biosci (Elite edition) 5:167–177. https://doi.org/10.2741/e605 Prokic I, Cowling BS, Laporte J (2014) Amphiphysin 2 (BIN1) in physiology and diseases. J Mol Med (Berlin, Germany) 92:453–463. https://doi.org/10.1007/s00109-014-1138-1 Prokop S, Miller KR, Heppner FL (2013) Microglia actions in Alzheimer’s disease. Acta Neuropathol 126:461–477. https://doi.org/10.1007/s00401-013-1182-x Rajendran L, Annaert W (2012) Membrane trafficking pathways in Alzheimer’s disease. Traffic (Copenhagen, Denmark) 13:759–770. https://doi.org/10.1111/j.1600-0854.2012.01332.x Ramjaun AR, McPherson PS (1998) Multiple amphiphysin II splice variants display differential clathrin binding: identification of two distinct clathrin-binding sites. J Neurochem 70:2369–2376. https://doi.org/10.1046/j.1471-4159.1998.70062369.x Ramjaun AR, Micheva KD, Bouchelet I, McPherson PS (1997) Identification and characterization of a nerve terminal-enriched amphiphysin isoform. J Biol Chem 272:16700–16706. https://doi.org/10.1074/jbc.272.26.16700 Sakamuro D, Prendergast GC (1999) New Myc-interacting proteins: a second Myc network emerges. Oncogene 18:2942–2954. https://doi.org/10.1038/sj.onc.1202725 Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC (1996) BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 14:69–77. https://doi.org/10.1038/ng0996-69 Sartori M et al (2019) BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr(348) phosphorylation. Acta Neuropathol 138:631–652. https://doi.org/10.1007/s00401-019-02017-9 Sato C et al (2018) Tau kinetics in neurons and the human central nervous system. Neuron 98:861–864. https://doi.org/10.1016/j.neuron.2018.04.035 Seshadri S et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832–1840. https://doi.org/10.1001/jama.2010.574 Sheedy FJ et al (2013) CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14:812–820. https://doi.org/10.1038/ni.2639 Shupliakov O et al (1997) Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science (New York, NY) 276:259–263. https://doi.org/10.1126/science.276.5310.259 Slepnev VI, De Camilli P (2000) Accessory factors in clathrin-dependent synaptic vesicle endocytosis. Nat Rev Neurosci 1:161–172. https://doi.org/10.1038/35044540 Sottejeau Y et al (2015) Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain. Acta Neuropathol Commun 3:58. https://doi.org/10.1186/s40478-015-0237-8 Stoorvogel W, Oorschot V, Geuze HJ (1996) A novel class of clathrin-coated vesicles budding from endosomes. J Cell Biol 132:21–33. https://doi.org/10.1083/jcb.132.1.21 Sun L, Tan MS, Hu N, Yu JT, Tan L (2013) Exploring the value of plasma BIN1 as a potential biomarker for Alzheimer’s disease. J Alzheimer’s Dis 37:291–295. https://doi.org/10.3233/jad-130392 Tajiri T et al (2003) Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Clin Cancer Res Off J Am Assoc Cancer Res 9:3345–3355 Tan MS, Yu JT, Tan L (2013) Bridging integrator 1 (BIN1): form, function, and Alzheimer’s disease. Trends Mol Med 19:594–603. https://doi.org/10.1016/j.molmed.2013.06.004 Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283:29615–29619. https://doi.org/10.1074/jbc.R800019200 Tjondrokoesoemo A et al (2011) Disrupted membrane structure and intracellular Ca2+ signaling in adult skeletal muscle with acute knockdown of Bin1. PLoS ONE 6:e25740. https://doi.org/10.1371/journal.pone.0025740 Ubelmann F, Burrinha T, Salavessa L, Gomes R, Ferreira C, Moreno N, Guimas Almeida C (2017) Bin1 and CD2AP polarise the endocytic generation of beta-amyloid. EMBO Rep 18:102–122. https://doi.org/10.15252/embr.201642738 Van Acker ZP, Bretou M, Annaert W (2019) Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors. Mol Neurodegener 14:20. https://doi.org/10.1186/s13024-019-0323-7 Wang HF et al (2016) Bridging integrator 1 (BIN1) genotypes mediate Alzheimer’s disease risk by altering neuronal degeneration. J Alzheimer’s Dis 52:179–190. https://doi.org/10.3233/jad-150972 Wang Y et al (2017) The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener 12:5. https://doi.org/10.1186/s13024-016-0143-y Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J, Prendergast GC (1997) Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem 272:31453–31458. https://doi.org/10.1074/jbc.272.50.31453 Wigge P, Kohler K, Vallis Y, Doyle CA, Owen D, Hunt SP, McMahon HT (1997) Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell 8:2003–2015. https://doi.org/10.1091/mbc.8.10.2003 Wixler V et al (1999) Identification of novel interaction partners for the conserved membrane proximal region of alpha-integrin cytoplasmic domains. FEBS Lett 445:351–355. https://doi.org/10.1016/s0014-5793(99)00151-9 Zhao Y, Keen JH (2008) Gyrating clathrin: highly dynamic clathrin structures involved in rapid receptor recycling. Traffic (Copenhagen, Denmark) 9:2253–2264. https://doi.org/10.1111/j.1600-0854.2008.00819.x